A citation-based method for searching scientific literature

Li-Shiun Chen, Timothy B Baker, Douglas Jorenby, Megan Piper, Nancy Saccone, Eric Johnson, Naomi Breslau, Dorothy Hatsukami, Robert M Carney, Laura J Bierut. Drug Alcohol Depend 2015
Times Cited: 24







List of co-cited articles
192 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.
Scott F Saccone, Anthony L Hinrichs, Nancy L Saccone, Gary A Chase, Karel Konvicka, Pamela A F Madden, Naomi Breslau, Eric O Johnson, Dorothy Hatsukami, Ovide Pomerleau,[...]. Hum Mol Genet 2007
629
50

Variants in nicotinic receptors and risk for nicotine dependence.
Laura Jean Bierut, Jerry A Stitzel, Jen C Wang, Anthony L Hinrichs, Richard A Grucza, Xiaoling Xuei, Nancy L Saccone, Scott F Saccone, Sarah Bertelsen, Louis Fox,[...]. Am J Psychiatry 2008
466
45

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.
Thorgeir E Thorgeirsson, Frank Geller, Patrick Sulem, Thorunn Rafnar, Anna Wiste, Kristinn P Magnusson, Andrei Manolescu, Gudmar Thorleifsson, Hreinn Stefansson, Andres Ingason,[...]. Nature 2008
45

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Andrew W Bergen, Harold S Javitz, Ruth Krasnow, Denise Nishita, Martha Michel, David V Conti, Jinghua Liu, Won Lee, Christopher K Edlund, Sharon Hall,[...]. Pharmacogenet Genomics 2013
60
45

CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
Li-Shiun Chen, Rayjean J Hung, Timothy Baker, Amy Horton, Rob Culverhouse, Nancy Saccone, Iona Cheng, Bo Deng, Younghun Han, Helen M Hansen,[...]. J Natl Cancer Inst 2015
53
41

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.
Nancy L Saccone, Robert C Culverhouse, Tae-Hwi Schwantes-An, Dale S Cannon, Xiangning Chen, Sven Cichon, Ina Giegling, Shizhong Han, Younghun Han, Kaisu Keskitalo-Vuokko,[...]. PLoS Genet 2010
281
41

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
Li-Shiun Chen, Timothy B Baker, Megan E Piper, Naomi Breslau, Dale S Cannon, Kimberly F Doheny, Stephanie M Gogarten, Eric O Johnson, Nancy L Saccone, Jen C Wang,[...]. Am J Psychiatry 2012
97
41

Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
Jane E Sarginson, Joel D Killen, Laura C Lazzeroni, Stephen P Fortmann, Heather S Ryan, Alan F Schatzberg, Greer M Murphy. Am J Med Genet B Neuropsychiatr Genet 2011
66
37

Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
Rachel F Tyndale, Andy Z X Zhu, Tony P George, Paul Cinciripini, Larry W Hawk, Robert A Schnoll, Gary E Swan, Neal L Benowitz, Daniel F Heitjan, Caryn Lerman. PLoS One 2015
28
37

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.
Thorgeir E Thorgeirsson, Daniel F Gudbjartsson, Ida Surakka, Jacqueline M Vink, Najaf Amin, Frank Geller, Patrick Sulem, Thorunn Rafnar, Tõnu Esko, Stefan Walter,[...]. Nat Genet 2010
521
37

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.
Christopher I Amos, Xifeng Wu, Peter Broderick, Ivan P Gorlov, Jian Gu, Timothy Eisen, Qiong Dong, Qing Zhang, Xiangjun Gu, Jayaram Vijayakrishnan,[...]. Nat Genet 2008
938
33

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
A Z X Zhu, Q Zhou, L S Cox, S P David, J S Ahluwalia, N L Benowitz, R F Tyndale. Clin Pharmacol Ther 2014
35
33

Meta-analysis and imputation refines the association of 15q25 with smoking quantity.
Jason Z Liu, Federica Tozzi, Dawn M Waterworth, Sreekumar G Pillai, Pierandrea Muglia, Lefkos Middleton, Wade Berrettini, Christopher W Knouff, Xin Yuan, Gérard Waeber,[...]. Nat Genet 2010
477
33

Genome-wide meta-analyses of smoking behaviors in African Americans.
S P David, A Hamidovic, G K Chen, A W Bergen, J Wessel, J L Kasberger, W M Brown, S Petruzella, E L Thacker, Y Kim,[...]. Transl Psychiatry 2012
78
33

Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
Caryn Lerman, Robert A Schnoll, Larry W Hawk, Paul Cinciripini, Tony P George, E Paul Wileyto, Gary E Swan, Neal L Benowitz, Daniel F Heitjan, Rachel F Tyndale. Lancet Respir Med 2015
180
29

CHRNA3 rs1051730 genotype and short-term smoking cessation.
Marcus R Munafò, Elaine C Johnstone, Donna Walther, George R Uhl, Michael F G Murphy, Paul Aveyard. Nicotine Tob Res 2011
59
29

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
David P King, Sara Paciga, Eve Pickering, Neal L Benowitz, Laura J Bierut, David V Conti, Jaakko Kaprio, Caryn Lerman, Peter W Park. Neuropsychopharmacology 2012
70
29

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.
Robert A Schnoll, Freda Patterson, E Paul Wileyto, Rachel F Tyndale, Neal Benowitz, Caryn Lerman. Pharmacol Biochem Behav 2009
156
29

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.
Rayjean J Hung, James D McKay, Valerie Gaborieau, Paolo Boffetta, Mia Hashibe, David Zaridze, Anush Mukeria, Neonilia Szeszenia-Dabrowska, Jolanta Lissowska, Peter Rudnai,[...]. Nature 2008
919
29

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Li-Shiun Chen, A Joseph Bloom, Timothy B Baker, Stevens S Smith, Megan E Piper, Maribel Martinez, Nancy Saccone, Dorothy Hatsukami, Alison Goate, Laura Bierut. Addiction 2014
60
25

A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Anu Loukola, Jadwiga Buchwald, Richa Gupta, Teemu Palviainen, Jenni Hällfors, Emmi Tikkanen, Tellervo Korhonen, Miina Ollikainen, Antti-Pekka Sarin, Samuli Ripatti,[...]. PLoS Genet 2015
74
25


Novel genes identified in a high-density genome wide association study for nicotine dependence.
Laura Jean Bierut, Pamela A F Madden, Naomi Breslau, Eric O Johnson, Dorothy Hatsukami, Ovide F Pomerleau, Gary E Swan, Joni Rutter, Sarah Bertelsen, Louis Fox,[...]. Hum Mol Genet 2007
468
25

Effect of the rs1051730-rs16969968 variant and smoking cessation treatment: a meta-analysis.
Tiffany Leung, Andrew Bergen, Marcus Robert Munafò, Kim De Ruyck, Peter Selby, Vincenzo De Luca. Pharmacogenomics 2015
12
41

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
F Patterson, R A Schnoll, E P Wileyto, A Pinto, L H Epstein, P G Shields, L W Hawk, R F Tyndale, N Benowitz, C Lerman. Clin Pharmacol Ther 2008
131
20

Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25.
Li-Shiun Chen, Nancy L Saccone, Robert C Culverhouse, Paige M Bracci, Chien-Hsiun Chen, Nicole Dueker, Younghun Han, Hongyan Huang, Guangfu Jin, Takashi Kohno,[...]. Genet Epidemiol 2012
59
20

Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.
Jen C Wang, Carlos Cruchaga, Nancy L Saccone, Sarah Bertelsen, Pengyuan Liu, John P Budde, Weimin Duan, Louis Fox, Richard A Grucza, Jason Kern,[...]. Hum Mol Genet 2009
146
20

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.
Sreekumar G Pillai, Dongliang Ge, Guohua Zhu, Xiangyang Kong, Kevin V Shianna, Anna C Need, Sheng Feng, Craig P Hersh, Per Bakke, Amund Gulsvik,[...]. PLoS Genet 2009
490
20

A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy.
Rachel M Freathy, Susan M Ring, Beverley Shields, Bruna Galobardes, Beatrice Knight, Michael N Weedon, George Davey Smith, Timothy M Frayling, Andrew T Hattersley. Hum Mol Genet 2009
110
20

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.
C Lerman, C Jepson, E P Wileyto, F Patterson, R Schnoll, M Mroziewicz, N Benowitz, R F Tyndale. Clin Pharmacol Ther 2010
79
20

Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking.
W Berrettini, X Yuan, F Tozzi, K Song, C Francks, H Chilcoat, D Waterworth, P Muglia, V Mooser. Mol Psychiatry 2008
365
20

Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Jed E Rose, Frédérique M Behm, Tomas Drgon, Catherine Johnson, George R Uhl. Mol Med 2010
97
16

Biomarkers for smoking cessation.
K J Bough, C Lerman, J E Rose, F J McClernon, P J Kenny, R F Tyndale, S P David, E A Stein, G R Uhl, D V Conti,[...]. Clin Pharmacol Ther 2013
44
16

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.
Sean P David, David R Strong, Adam M Leventhal, Molly A Lancaster, John E McGeary, Marcus R Munafò, Andrew W Bergen, Gary E Swan, Neal L Benowitz, Rachel F Tyndale,[...]. Addiction 2013
22
18

Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes.
Timothy B Baker, Robert B Weiss, Daniel Bolt, Andrew von Niederhausern, Michael C Fiore, Diane M Dunn, Megan E Piper, Nori Matsunami, Stevens S Smith, Hilary Coon,[...]. Nicotine Tob Res 2009
99
16

Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
A Joseph Bloom, Sarah M Hartz, Timothy B Baker, Li-Shiun Chen, Megan E Piper, Louis Fox, Maribel Martinez, Dorothy Hatsukami, Eric O Johnson, Cathy C Laurie,[...]. Ann Am Thorac Soc 2014
30
16

Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.
Christie D Fowler, Qun Lu, Paul M Johnson, Michael J Marks, Paul J Kenny. Nature 2011
446
16

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Kerri A Schoedel, Ewa B Hoffmann, Yushu Rao, Edward M Sellers, Rachel F Tyndale. Pharmacogenetics 2004
227
16

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.
Jane E Sarginson, Joel D Killen, Laura C Lazzeroni, Stephen P Fortmann, Heather S Ryan, Niloufar Ameli, Alan F Schatzberg, Greer M Murphy. Nicotine Tob Res 2015
11
36

Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.
Maria N Timofeeva, Rayjean J Hung, Thorunn Rafnar, David C Christiani, John K Field, Heike Bickeböller, Angela Risch, James D McKay, Yufei Wang, Juncheng Dai,[...]. Hum Mol Genet 2012
149
16

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Kim De Ruyck, Kristiaan Nackaerts, Laurence Beels, Joke Werbrouck, Annick De Volder, Marc Meysman, Bihiyga Salhi, Jan Van Meerbeeck, Hubert Thierens. Pharmacogenomics 2010
29
16

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Kate Cahill, Sarah Stevens, Rafael Perera, Tim Lancaster. Cochrane Database Syst Rev 2013
695
16

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
Delia Dempsey, Piotr Tutka, Peyton Jacob, Faith Allen, Kerri Schoedel, Rachel F Tyndale, Neal L Benowitz. Clin Pharmacol Ther 2004
313
16

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Caryn Lerman, Rachel Tyndale, Freda Patterson, E Paul Wileyto, Peter G Shields, Angela Pinto, Neal Benowitz. Clin Pharmacol Ther 2006
202
16

Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15.
Kaisu Keskitalo, Ulla Broms, Markku Heliövaara, Samuli Ripatti, Ida Surakka, Markus Perola, Janne Pitkäniemi, Leena Peltonen, Arpo Aromaa, Jaakko Kaprio. Hum Mol Genet 2009
88
16

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Kevin P Jensen, Elise E DeVito, Aryeh I Herman, Gerald W Valentine, Joel Gelernter, Mehmet Sofuoglu. Neuropsychopharmacology 2015
45
16

Pathways to precision medicine in smoking cessation treatments.
Li-Shiun Chen, Amy Horton, Laura Bierut. Neurosci Lett 2018
22
18

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
Ewoud Schuit, Orestis A Panagiotou, Marcus R Munafò, Derrick A Bennett, Andrew W Bergen, Sean P David. Cochrane Database Syst Rev 2017
26
16

Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.
Michael Mamoun, Andrew W Bergen, Jennifer Shieh, Anna Wiggins, Arthur L Brody. CNS Drugs 2015
17
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.